Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Tonix Pharm Holdings (TNXP)

Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 35,510
  • Shares Outstanding, K 186,894
  • Annual Sales, $ 7,770 K
  • Annual Income, $ -116,660 K
  • EBIT $ -142 M
  • EBITDA $ -137 M
  • 60-Month Beta 2.06
  • Price/Sales 4.91
  • Price/Cash Flow N/A
  • Price/Book 0.43
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -52.74
  • Most Recent Earnings $-0.23 on 11/12/24
  • Next Earnings Date 11/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -1.84
  • Number of Estimates 2
  • High Estimate -0.22
  • Low Estimate -3.45
  • Prior Year -27.48
  • Growth Rate Est. (year over year) +93.30%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1264 +51.90%
on 11/18/24
0.2763 -30.51%
on 11/20/24
+0.0265 (+16.01%)
since 10/25/24
3-Month
0.1180 +62.71%
on 10/03/24
0.4600 -58.26%
on 08/26/24
-0.1480 (-43.53%)
since 08/23/24
52-Week
0.1180 +62.71%
on 10/03/24
22.1376 -99.13%
on 12/19/23
-15.3600 (-98.77%)
since 11/24/23

Most Recent Stories

More News
Tonix Pharmaceuticals Reports Positive Phase 3 Results for TNX-102 SL in Fibromyalgia, Submits NDA to FDA

Tonix Pharmaceuticals presented Phase 3 RESILIENT study results for TNX-102 SL, showing significant improvements in fibromyalgia symptoms. NDA submitted to FDA.Quiver AI SummaryTonix Pharmaceuticals presented...

TNXP : 0.1920 (+1.05%)
Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual

TNXP : 0.1920 (+1.05%)
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

TNXP : 0.1920 (+1.05%)
Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

TNXP : 0.1920 (+1.05%)
Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals

TNXP : 0.1920 (+1.05%)
Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights

TNXP : 0.1920 (+1.05%)
Will Trump 2.0 Nurse Biotechs Back To Health: 10 Stocks Retail Is Watching

Less stringent requirements in pharmaceuticals and biotechnology could help biotechs by prompting accelerated drug approvals.

SRNE : 0.0025 (unch)
TNXP : 0.1920 (+1.05%)
IBB : 139.91 (+1.41%)
JAGX : 1.0300 (-0.96%)
NVAX : 9.32 (+10.04%)
INO : 4.13 (+1.47%)
GILD : 90.49 (+0.33%)
MRNA : 43.66 (+6.20%)
VXRT : 0.6121 (+2.02%)
IBIO : 2.56 (-3.03%)
XBI : 97.63 (+1.44%)
PFE : 26.17 (+2.03%)
Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya

TNXP : 0.1920 (+1.05%)
Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024

TNXP : 0.1920 (+1.05%)
Tonix Pharmaceuticals to Present at BIO-Europe® 2024

TNXP : 0.1920 (+1.05%)

Business Summary

Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102,...

See More

Key Turning Points

3rd Resistance Point 0.2318
2nd Resistance Point 0.2215
1st Resistance Point 0.2067
Last Price 0.1920
1st Support Level 0.1816
2nd Support Level 0.1713
3rd Support Level 0.1565

See More

52-Week High 22.1376
Fibonacci 61.8% 13.7261
Fibonacci 50% 11.1278
Fibonacci 38.2% 8.5295
Last Price 0.1920
52-Week Low 0.1180

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar